Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254)
暂无分享,去创建一个
V. Kraus | Virginia B Kraus | Thomas V Stabler | Carl R Flannery | C. Flannery | Jonathan B Catterall | J. Catterall | T. Stabler
[1] H. Iwaso,et al. Intraarticular inflammatory cytokines in acute anterior cruciate ligament injured knee. , 2003, The Knee.
[2] J. Dingle,et al. In vivo studies of cartilage regeneration after damage induced by catabolin/interleukin-1. , 1991, Annals of the rheumatic diseases.
[3] T. P. Misko,et al. Protein geranylgeranylation controls collagenase expression in osteoarthritic cartilage. , 2010, Osteoarthritis and cartilage.
[4] D. Eyre,et al. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. , 2003, Arthritis and rheumatism.
[5] Lewis Thomas,et al. REVERSIBLE COLLAPSE OF RABBIT EARS AFTER INTRAVENOUS PAPAIN, AND PREVENTION OF RECOVERY BY CORTISONE , 1956, The Journal of experimental medicine.
[6] L. Ryd,et al. Increased levels of proteoglycan fragments in knee joint fluid after injury. , 1989, Arthritis and rheumatism.
[7] H. Ma,et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. , 2004, Arthritis and rheumatism.
[8] R. Eastell,et al. Effect of Pamidronate in Preventing Local Bone Loss After Total Hip Arthroplasty: A Randomized, Double‐Blind, Controlled Trial , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[9] H. Muir,et al. Demonstration of increased proteoglycan turnover in cartilage explants from dogs with experimental osteoarthritis , 1984, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[10] J. Isaacs. The changing face of rheumatoid arthritis: sustained remission for all? , 2010, Nature Reviews Immunology.
[11] J. Boehm,et al. Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. , 2000, Arthritis and rheumatism.
[12] M. Hochberg,et al. Joint Injury in Young Adults and Risk for Subsequent Knee and Hip Osteoarthritis , 2000, Annals of Internal Medicine.
[13] L. Lohmander,et al. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. , 1993, Arthritis and rheumatism.
[14] S Totterman,et al. The acutely ACL injured knee assessed by MRI: are large volume traumatic bone marrow lesions a sign of severe compression injury? , 2008, Osteoarthritis and cartilage.
[15] J. Jordan,et al. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. , 2006, Arthritis and rheumatism.
[16] L. Lohmander,et al. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. , 1992, The Journal of clinical investigation.
[17] M. Rivera-Bermúdez,et al. Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor. , 2011, Osteoarthritis and cartilage.
[18] A. Ratcliffe,et al. Increased release of matrix components from articular cartilage in experimental canine osteoarthritis , 1992, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[19] A. Sudo,et al. Changes in biochemical markers and prediction of effectiveness of intra-articular hyaluronan in patients with knee osteoarthritis. , 2008, Osteoarthritis and cartilage.
[20] D. Heinegård,et al. Cartilage metabolism in the injured and uninjured knee of the same patient. , 1994, Annals of the rheumatic diseases.
[21] Thomas D Brown,et al. Posttraumatic Osteoarthritis: A First Estimate of Incidence, Prevalence, and Burden of Disease , 2006, Journal of orthopaedic trauma.
[22] Claus Christiansen,et al. Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity , 2008, Arthritis research & therapy.
[23] H. Roos,et al. Temporal patterns of stromelysin‐1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus , 1994, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[24] Jason P. Gleghorn,et al. Prevention of cartilage degeneration in a rat model of osteoarthritis by intraarticular treatment with recombinant lubricin. , 2009, Arthritis and rheumatism.
[25] K. Duffin,et al. A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAs. , 2010, Osteoarthritis and cartilage.
[26] H. Roos,et al. Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injury. , 1993, The Journal of rheumatology.
[27] P. Tak,et al. Soluble Biomarkers of Cartilage and Bone Metabolism in Early Proof of Concept Trials in Psoriatic Arthritis: Effects of Adalimumab Versus Placebo , 2010, PloS one.
[28] B. Mazières,et al. Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study , 2007, Annals of the rheumatic diseases.
[29] V. Kraus,et al. Amino acid racemization reveals differential protein turnover in osteoarthritic articular and meniscal cartilages , 2009, Arthritis research & therapy.
[30] W. Lems,et al. Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. , 2010, Osteoarthritis and cartilage.
[31] Thomas P Andriacchi,et al. Knee kinematics, cartilage morphology, and osteoarthritis after ACL injury. , 2008, Medicine and science in sports and exercise.
[32] T. Cawston,et al. Drugs in development: bisphosphonates and metalloproteinase inhibitors , 2002, Arthritis research & therapy.
[33] E. Roos,et al. Joint injury causes knee osteoarthritis in young adults , 2005, Current opinion in rheumatology.
[34] A R Poole,et al. Application of Biomarkers in the Development of Drugs Intended for the Treatment of Osteoarthritis OARSI FDA Osteoarthritis Biomarkers Working Group , 2011 .
[35] H. Ma,et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis , 2005, Nature.
[36] S. Heitmeyer,et al. P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis , 2008, Journal of Inflammation.
[37] T. Cawston,et al. Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture. , 1995, Biochemical and biophysical research communications.
[38] T. Cawston,et al. Sulfasalazine blocks the release of proteoglycan and collagen from cytokine stimulated cartilage and down-regulates metalloproteinases. , 2009, Rheumatology.
[39] E. Roos,et al. The Long-term Consequence of Anterior Cruciate Ligament and Meniscus Injuries , 2007, The American journal of sports medicine.
[40] D. Heinegård,et al. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. , 1994, Annals of the rheumatic diseases.
[41] R W Jubb,et al. The breakdown of collagen by chondrocytes , 1980, The Journal of pathology.
[42] K. Pavelka,et al. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. , 2002, Osteoarthritis and cartilage.
[43] V. Kraus,et al. Post-translational aging of proteins in osteoarthritic cartilage and synovial fluid as measured by isomerized aspartate , 2009, Arthritis research & therapy.
[44] D. Young,et al. Lipophilic statins prevent matrix metalloproteinase-mediated cartilage collagen breakdown by inhibiting protein geranylgeranylation , 2010, Annals of the rheumatic diseases.
[45] B. Caterson,et al. Articular cartilage metabolism in patients with Kashin-Beck Disease: an endemic osteoarthropathy in China. , 2008, Osteoarthritis and cartilage.
[46] J. Buckwalter,et al. The impact of osteoarthritis: implications for research. , 2004, Clinical orthopaedics and related research.
[47] L. Lohmander,et al. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. , 1993, Arthritis and rheumatism.
[48] M. Jefferson,et al. Lithium protects cartilage from cytokine-mediated degradation by reducing collagen-degrading MMP production via inhibition of the P38 mitogen-activated protein kinase pathway. , 2010, Rheumatology.